Zymeworks Inc.: TD Cowen reinstates coverage with buy rating; price target $34
ZYME•TD Cowen reinstated coverage of Zymeworks with a buy rating and a $34 price target.
Related News
CoreLogic: US home prices rise 1.9% y/y in July, Case-Shiller shows
SPY•
Lloyds Banking Group announces gross dividend of R$ 0.4200413540 per unit, payable Oct. 1, 2026
LYG•
CarMax's quarterly profit, revenue rise as pricing boosts used-car sales
KMX•
Apple's new CEO moves to overhaul company to run faster and leaner
AAPL•
Spotify down for thousands of users in US, Downdetector shows
SPOT•